Diretor do curso
Diretor do Departamento Coração e Vasos do CHULN
Prof. Catedrático de Cardiologia FMUL
14h | Registration |
14h15 | Welcome remarks |
Prof. Fausto Pinto e Profa. Manuela Fiuza |
14h30 | Amyloidosis AL |
Clinical case (with polleverywhere voting) Catarina Gregório |
The Spectrum of plasmatic Dyscrasias Manuel Neves |
15h | International Conference: Cardiac Amyloidosis: Unmasking the Great Pretender Daniel Lenihan |
Chairs: Andreia Magalhães e Carlos Martins |
15h30 | Immuno-Oncology |
International Conference: Cardiovascular complications of immune checkpoint inhibitors Daniel Zlotoff |
Clinical case (with polleverywhere voting) João Araújo |
Let’s understand what antitumor immunity is Emanuel Gouveia |
Chairs: Manuela Fiuza e Joana Vaz |
16h30 | Coffee Break |
16h40 | Cardiovascular risk of oncological therapies |
Clinical case (with polleverywhere voting) Mariana Câmara |
Fluoropyridines in colorectal cancer Helena Luna Pais |
Cardiotoxicity associated with fluoropyridines: A systematic review Júlia Toste |
Treatment of Lung Cancer: State of the art in 2023 Teresa Pacheco |
Chairs: Ana Carolina Vasques e Miguel Menezes |
18h10 | Adjourn |
9h | Welcome back |
9h15 | Breast cancer: Multidisciplinary approach |
Clinical case (with polleverywhere voting) Pedro Silva |
Breast cancer: What we know and what we still don’t know about the cardiovascular toxicity of current therapies Leonor Ribeiro |
Monitoring during treatment and “permissive” cardiotoxicity Mariana Paiva |
“Moon Shot” in cancer therapy Maria Rita Dionísio |
Chairs: Manuela Fiuza e Catarina Abreu |
10h30 | Assessment and detection of cardiovascular risk |
CVRF, incidence of cancer and reverse cardiotoxicity Mariana Paiva |
CT staging in lymphoma: A missed opportunity for cardiovascular risk stratification? Beatriz Silva |
Hormone deprivation therapy in treatment of prostate cancer how to minimize cardiovascular risk? Patrício Aguiar |
Hormone deprivation therapy in treatment of prostate
cancer how to minimize cardiovascular risk? - What the 2022 Guidelines say Andreia Magalhães |
Chairs: Daniel Caldeira e Gizela Rocha |
11h30 | Coffee break |
11h45 | Arrhythmology in cancer patients |
Af secondary to BTK inhibitors Daniela Alves |
AF in cancer patients: Do traditional paradigms still apply? Nuno Cortez Dias |
12h30 | International Conference: Arrhythmias in cancer patients Michael Fradley |
Chairs: Andreia Magalhães e Nuno Cortez Dias |
13h | Lunch |
14h | International Conference: Digital Health in cardio-oncology Jose Juanatey |
14h20 | Coronary and structural intervention in patients with cancer |
Coronary disease and the cancer patient Miguel Menezes |
Approach to valvular disease in cancer survivors Cláudia Jorge |
15h | International Conference: Management of coronary revascularization in cancer Mamas A. Mamas |
Chairs: Miguel Menezes e Fausto Pinto |
15h30 | Heart failure in cancer patients |
Clinical case (with polleverywhere voting) Beatriz Garcia |
Acute and chronic heart failure in cancer patients Doroteia Silva |
Image multimodality: which, when and why Joana Rigueira |
Chairs: Rui Plácido e João Agostinho |
16h15 | Coffee Break |
16h25 | Vascular complications in the patient with cancer |
Venous thrombosis and anticoagulant: what the new SEC and ESMO guidelines say Beatriz Silva |
Pulmonary hypertension in cancer patients: causes, diagnosis and treatment Rui Plácido |
Carcinoid syndrome and cardiac involvement Mariana Saraiva |
Chairs: Júlia Toste e Miguel Menezes |
17h30 | Long survivors: Strategies for the monitoring and intervention |
Cardiovascular disease induced by radiotherapy and new modalities to mitigate it Maria Eduarda Neves |
Cardio-Oncological rehabilitation: what are the opportunities and bariers? Ana Abreu |
Long-term monitoring and intervention strategies in cancer survivors Manuela Fiuza |
Chairs: Mariana Saraiva e Diogo Delgado |
Diretor do curso
Diretor do Departamento Coração e Vasos do CHULN
Prof. Catedrático de Cardiologia FMUL
Direção e Comissão Organizadora AHG Cardiologia
CHULN Prof. Aux. Cardiologia FMUL
AH Cardiologia CHULN
Assistente FMUL
AH Cardiologia CHULN
Assistente FMUL
Immediate Past President of IC-OS
Professor of Medicine-Cardiology Saint Francis Healthcare System
Missouri, USA
Instructor of Medicine Harvard Medical School
Assistant in Medicine-Cardiology Massachusetts General Hospital
Boston, USA
Clinical Director Center for Prognosis Research
Professor of Interventional Cardiology University of Keele
Staffordshire, UK
Medical Director Thalheimer Center for Cardio-Oncology
Assoc. Professor of Medicine-Cardiology Penn Heart and Vascular Center
Philadelphia, USA
Head of Cardiology and UCC Service SCU Hospital
Professor of Cardiology Hospital Clínico USC
Santiago de Compostela, ES
Cardiologia; CHULN, PT
Oncologia; CHLO, PT
Cardiologia; CHULN, PT
Cardiologia; CHULN, PT
Cardiologia; CHULN, PT
Hematologia; CHULN, PT
Oncologia; CHULN, PT
Cardiologia; CHULN, PT
Cardiologia; CHULN, PT
Cardiologia; CHULN, PT
Hematologia; CHULN, PT
Radio-Oncologia; CHULN, PT
SMI; CHULN, PT
Oncologia; IPO-FG, PT
Cardiologia; CHULN, PT
Oncologia; CHULN, PT
Oncologia; CHULN, PT
Cardiologia; CHULN, PT
Oncologia; IPO-FG, PT
Cardiologia; CHULN, PT
Oncologia; CHULN, PT
Cardiologia; H. Luz
Oncologia; CHULN, PT
Hematologia; F. Champalimaud, PT
Cardiologia; CHULN, PT
Radio-Oncologia; CHULN, PT
Oncologia
Oncologia; H. Luz
Cardiologia; CHUSJ, PT
Cardiologia; H. Santarém, PT
Cardiologia; CHULN, PT
Cardiologia; CHULN, PT
Medicina; CHULN, PT
Cardiologia; CHULN, PT
Cardiologia; CHULN, PT
Cardiologia; CHULN, PT
Oncologia; CHULN, PT
For further information please contact:
Tel: +351 217 985 186; e-mail: cardiooncologycourse@gmail.com